FDA Debates Future of Breast Cancer Drug Avastin

Author:
Publish date:
Social count:
0

The best-selling cancer drug in the world comes under federal scrutiny once again this week, as the FDA hears arguments to keep Avastin approved for breast cancer treatment. More from the Associated Press:

undefined

Popular Video